Yupelri (revefenacin) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a liquid solution for inhalation with a jet nebulizer. It’s typically ...
If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you ...
After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
Sunovion’s COPD treatment passed muster in Phase III for both safety and efficacy, marking a success for its quick-acting nebulizer delivery system. The SUN-101/eFlow system, described as a ...
The US Food and Drug Administration (FDA) has approved glycopyrrolate inhalation solution 25 mcg twice daily (Lonhala Magnair, Sunovion Pharmaceuticals) for maintenance treatment of airflow ...
Use nebulizer and inhaler for the treatment. Young woman inhaling through inhaler mask lying on the couch and chatting in mobile phone. Closeup front view Researchers conducted subgroup analysis of ...
Sunovion Pharmaceuticals of Marlborough announced the start of a phase 3 clinical trial program for SUN-101, an inhalation solution being investigated for the treatment of chronic obstructive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback